http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009021656-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d4834a2cb6bdd248186ccfb47546e9e4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_cdaac3a7bf5b6c5ab11b5883f2f82987
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_849db2efd58fe7fdbb4cd28233f0707b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e2bd69b9b9624043ce5a376f2a40b071
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d0c33e9c37accdcb92ea2c614279d0a5
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D211-22
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-445
filingDate 2008-08-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_790b2fca7c24d79bf9b369986c3bc019
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_becf030cfb0bfd5e37bcca4e074f440a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c39306ada0e1e11b4955348d2d2b21e8
publicationDate 2009-02-19-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2009021656-A2
titleOfInvention Tablet containing donepezile hydrochloride in amorphous form
abstract The present invention relates to a method for the production of a tablet containing the hydrochloride salt of donepezile in amorphous form, characterized in that a granulate is utilized during the compacting of a tablet mass comprising a granulate, in which a hydrochloride salt of donepezile is contained in a crystalline form. The present invention further relates to the use of a hydrochloride salt of donepezile in a crystalline form for the production of a granulate, wherein the granulate contains a hydrochloride salt of donepezile in a crystalline and dehydrated form.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9757338-B2
priorityDate 2007-08-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID24749
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395951
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393819
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127822818
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID136460
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3423265
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393946
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID104938
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3024046
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3152
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226413434
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226408288
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID443953
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394438
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127389349
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394441
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226394688
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226406928
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6251
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID969462
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID157355
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127389351
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395676
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127765137
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5741

Total number of triples: 47.